ACTHAR REV UP !

[anonymous]

Per accounting dept.

 

[anonymous]

I knew demand is high.

 

[anonymous]

That's very good to know.

 

[anonymous]

dont believe that BS for a second. I’ve seen all 5 KPI reports for June. Demand is flat to soft.

We are letting distributors and SP build inventories higher that normal. That’s why accounting is seeing a demand if they are really seeing it which i don’t believe for second.

 

[anonymous]

I could tell you don't work for Mallinckrodt.

 

[anonymous]

Payors are good with Acthar.

 

[anonymous]

yes payors are great with Acthar!!! Unless you are Optum, ESI, Tricare, CVS or one of the hundreds of others that don’t approve Acthar for most indications

You must be a IS rep. They rest of us have seen our rates drop to 50% or lower and it’s even worse in Pulm and Ophth.

 

[anonymous]

Those payors are coming online as well.

 

[anonymous]

this cracks me up. You have zero idea what you are talking about. They are gone and we are trying desperately to prevent a couple others from dropping up.

 

[anonymous]

Nonsense. Payors are coming online.

 

[anonymous]

Acthar Q2 rev close to $300M.

 

[anonymous]

That made me laugh. We were $244 million last quarter. Where did the extra $56 million come from because it wasn’t pulm?!?!

 

[anonymous]

That made me laugh. We were $244 million last quarter. Where did the extra $56 million come from because it wasn’t pulm?!?!

Good point Ed!

 

[anonymous]

You idiots haven't learned have you.
Q1 is always the lowest.

 

[anonymous]

Idiot

That made me laugh. We were $244 million last quarter. Where did the extra $56 million come from because it wasn’t pulm?!?!

 

[anonymous]

of course it is but your saying across the TAs there was a 20-25 increase in volume over Q1. I don’t buy it. Not unless we are playing some funny business with SP inventories.

 

[anonymous]

Very likely Acthar revenue will hit $300M for Q2. Q3-4 are looking strong as well.

 

[anonymous]

Very likely Acthar revenue will hit $300M for Q2. Q3-4 are looking strong as well.

”Q3-4 are looking strong as well”. Smoke and mirrors plus a crystal ball. Trifecta!

 

[anonymous]

Very likely Acthar revenue will hit $300M for Q2. Q3-4 are looking strong as well.

Haven’t you idiots learned by now? Never get high on your own supply.

 

[anonymous]

Q3 is looking so strong we are delaying Q3 goals to account for the impact of Optum RX which have no doubt is hurting us badly in some areas of the country.

Oh but wait Optum will come back just like CVS did!!! We all know how that worked out.